Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ConAgra’s Petition For Whole Grain/Diabetes Claim Draws Opposition

This article was originally published in The Tan Sheet

Executive Summary

Kellogg Co. disagrees with ConAgra’s petition to FDA for a qualified health claim linking whole grain consumption with reduced risk of type 2 diabetes. Other experts question ConAgra’s supporting evidence and maintain fiber content should be emphasized over whole grains in product labeling.

Advertisement

Related Content

FDA Speaks Loudly On Approved Claims Language In Post Foods Warning
FDA Speaks Loudly On Approved Claims Language In Post Foods Warning
In Brief
Nutrition Market Shifting From Supplements To Whole Foods – Experts
FDA Cheerios Warning Signals Tougher Stance On Health Claims Enforcement
Trade Groups Defend Qualified Health Claims Following Critical GAO Report

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105815

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel